Experimental cell therapy trial offers hope for transplant patients with Treatment-Resistant complications
Disease control
Not yet recruiting
This early-stage trial is testing whether a single infusion of specially grown immune cells (EVE-Treg cells) combined with daily low-dose interleukin-2 medication can help control chronic graft-versus-host disease that hasn't responded to standard steroid treatment. The study wil…
Phase: PHASE1 • Sponsor: Leslie Kean • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC